Puteri Ainaa S. Ibrahim

Puteri Ainaa S. Ibrahim

Auto-generated profile, based on publicly available information

Puteri Ainaa S. Ibrahim

Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya , Kuala Lumpur

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2025 in Journal of Infection
Verified
Journal Article
Open access
HOHui Ming Ong
Hui Ming Ong
PIPuteri Ainaa S. Ibrahim
Puteri Ainaa S. Ibrahim
CNChong Chee Ning
Chong Chee Ning
CTChong Tin Tan
Chong Tin Tan
JSJie Ping Schee
Jie Ping Schee
LCLi-Yen Chang
Li-Yen Chang
To evaluate the long-term humoral immune response to Nipah virus (NiV) in a cohort of 25 survivors after 25 years of post-infection. A total of 25 survivors of NiV infection from the 1998 outbreak were recruited for sample collection. The serum IgG antibody response to NiV antigens, specifically nucleocapsid (N), fusion glycoprotein (F) and attachment glycoprotein (G) was evaluated using ELISA. Additionally, the samples were tested for neutralizing antibodies and memory B cell responses. Detection rates of anti-NiV-F and anti-NiV-G were 56% and 60%, respectively, among the survivors at a 1:100 dilution, whereas only 20% were specifically reactive to rNiV-N. Notably, all samples that tested positive for NiV-F and NiV-G at this dilution also exhibited neutralizing antibodies, highlighting the specificity of these assays. Live virus neutralization assay showed that 72% of survivors had detectable neutralizing antibodies, with varying titers, indicating long-lasting immune memory. Furthermore, memory B cell responses specific to NiV-F and NiV-G were observed in six randomly selected survivors, suggesting the presence of enduring immunological memory. These findings highlight the potential of NiV-F and NiV-G as reliable markers for NiV exposure and underscore the need for continuous surveillance and research. Such efforts are crucial for advancing vaccine development and improving preparedness for future NiV outbreaks.

8 January 2026 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PIPuteri Ainaa S Ibrahim
Puteri Ainaa S Ibrahim
HOHui Ming Ong
Hui Ming Ong
HCHeng Choon Cheong
Heng Choon Cheong
CTChong Tin Tan
Chong Tin Tan
JSJie Ping Schee
Jie Ping Schee
LCLi-Yen Chang
Li-Yen Chang
Nipah virus (NiV) induces strong humoral immunity, but the durability of NiV-specific memory T-cell responses remains unclear. We characterized cellular immunity approximately 25 years after infection in 4 survivors of the 1998 Malaysian outbreak. PBMCs were stimulated with overlapping peptide mini-pools spanning the NiV fusion (NiV-F) and attachment (NiV-G) glycoproteins, and responses were assessed using enzyme-linked immune absorbent spot and intracellular cytokine staining. Durable cytokine-producing T-cell responses were detected, with immunodominant epitopes in the NiV-G ectodomain. Survivors with neurological sequelae exhibited stronger T-cell responses and cognitive impairment, highlighting persistent cellular immunity decades after infection with implications for vaccine development.